OpenAI has absorbed a drug-development coordination startup and folded it into Rosalind, its life-sciences model family.
The Rosalind Academic Plan opens GPT-Rosalind to vetted life-science labs, wiring the model into chemistry, genomics and experimental…
The company says its models need real experiments, not only simulated ones, to matter in biology.
OpenAI shares how coding agents accelerate scientific computing, from genomic library modernization to GPU-native redesigns.